Minimally invasive surgery for abdominal and thoracic neuroblastic tumors: A systematic review by the APSA Cancer committee
pubmed.ncbi.nlm.nih.gov shows its articles on its own site.
Read the article on pubmed.ncbi.nlm.nih.gov ↗Article · Oct 2026 · 1 min read
In brief
In brief
This APSA Cancer Committee systematic review evaluates minimally invasive approaches for neuroblastic tumor resection in children. Evidence supports MIS for smaller (4-6 cm) abdominal tumors without image-defined risk factors, while open approaches remain preferable for IDRF-positive or larger lesions.
Written by the GCMD Library team from the article.
Background: Minimally invasive surgery has broad applicability to pediatric diseases, including pediatric cancer resection. Neuroblastic tumors of childhood are highly variable in presentation, and so careful selection of appropriate candidates for minimally invasive resection is paramount to achieving safe and durable surgical and oncological outcomes. Methods: The American Pediatric Surgical Association Cancer Committee developed questions seeking to better define the role of minimally invasive surgery for neuroblastic tumors. A search using PubMed, Medline, Embase, Web of Science, ProQuest Dissertations, and Clinical Trials was performed for articles published from 1998 to 2018 in accordance with the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) guidelines. Results: The evidence identified is all retrospective in nature. Minimally invasive surgical resection of neuroblastic tumors is safe for carefully selected smaller (4-6 cm) image defined risk factor (IDRF)-negative abdominal tumors when oncologic principles are followed. Size is a less-well defined criterion for thoracic neuroblastic tumors. Open approaches for both abdominal and thoracic tumors may be preferable in the presence of IDRF's. Conclusion: Small tumors without IDRF's are reasonable candidates for minimally invasive resection. Surgical oncologic guidelines should be closely followed. The quality of data supporting this systematic review is poor and highlights the need
Educational content from recorded physician discussions — not medical advice. Talk to your (or your child's) care team about your situation.
Article
Impact of Hepatoblastoma on Infectious Complications Following Pediatric Liver Transplantation
Alexander Bondoc · Published Oct 2026
Article
Central nervous system immunological complications of immunotherapy in pediatrics.
Alberto Tozzi · Published Oct 2026
Article
Gaps and Opportunities of Artificial Intelligence Applications for Pediatric Oncology in European Research: A Systematic Review of Reviews and a Bibliometric Analysis.
Alberto Tozzi · Published Oct 2026
Video
Rare Ovarian Tumor in Infants: Small Cell Carcinoma of Ovary, Hypercalcemic Type & SMARCA4 Mutation
21 s · Published Oct 2026
Video
Can Normal X-Rays Miss Metastatic Neuroblastoma? A Pediatric Radiology Case Study
26 s · Published Oct 2026
Video
Can Fractures Be a Sign of Hepatoblastoma in Children? Understanding Pediatric Liver Cancer Symptoms
37 s · Published Oct 2026